Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2010
12/30/2010US20100330603 Portable microbiological testing device for gases
12/30/2010US20100330602 Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment
12/30/2010US20100330601 Control system for uv lamps, and check system for determining the viability of microorganisms
12/30/2010US20100330600 High-molecular-weight adiponectin measurement method
12/30/2010US20100330599 Inhibitors of usp1 deubiquitinating enzyme complex
12/30/2010US20100330598 METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR PROVIDING BOTH AN ESTIMATED TRUE MEAN BLOOD GLUCOSE VALUE AND ESTIMATED GLYCATED HEMOGLOBIN (HbA1C) VALUE FROM STRUCTURED SPOT MEASUREMENTS OF BLOOD GLUCOSE
12/30/2010US20100330597 Heat-Treated Limulus Amebocyte Lysates
12/30/2010US20100330596 Lipoprotein surfactant
12/30/2010US20100330590 Assays using chimeric t1r3 taste receptor polypeptides
12/30/2010US20100330589 Needle array assembly and method for delivering therapeutic agents
12/30/2010US20100330586 Method for identifying compounds for treatment of pain
12/30/2010US20100330581 Method for in vitro diagnosis or prognosis of testicular cancer
12/30/2010US20100330580 Method for the in vitro diagnosis or prognosis of testicular cancer
12/30/2010US20100330579 Detection of pcr products in gel electrophoresis
12/30/2010US20100330578 Thermo-optical characterisation of nucleic acid molecules
12/30/2010US20100330577 Methods for identification of an antibody or a target
12/30/2010US20100330576 Method, Kits, and Reaction Mixtures For High Resolution Melt Genotyping
12/30/2010US20100330575 Molecular diagnostics reagents and methods
12/30/2010US20100330574 Chimeric primers with hairpin conformations and methods of using same
12/30/2010US20100330573 Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetella
12/30/2010US20100330572 Organic compounds
12/30/2010US20100330571 Method of measuring adaptive immunity
12/30/2010US20100330570 Nucleotide transient binding for sequencing methods
12/30/2010US20100330569 Hydroxymethyl Linkers For Labeling Nucleotides
12/30/2010US20100330568 Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
12/30/2010US20100330567 Dna markers for management of cancer
12/30/2010US20100330566 Genetic polymorphisms in the prostate-specific antigen gene promoter
12/30/2010US20100330565 Reagent kit for sample analysis and sample analysis method
12/30/2010US20100330564 Nucleic acid detection method and nucleic acid detection kit
12/30/2010US20100330563 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
12/30/2010US20100330562 Unique Calibrator Polynucleotides and Methods of Using in Quantitative Nucleic Acid Assays
12/30/2010US20100330561 Marker Gene For Detection of Tumor Promoter, and Method For Detection of Tumor Promoter
12/30/2010US20100330560 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/30/2010US20100330559 Forensic identification
12/30/2010US20100330558 Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical Cancer
12/30/2010US20100330557 Genomic coordinate system
12/30/2010US20100330556 Genome analysis using a nicking endonuclease
12/30/2010US20100330555 Accuracy fluorescence in-situ hybridization assay of samples with apoptotic cells
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330553 Chemically induced optical signals and DNA sequencing
12/30/2010US20100330552 Comparative cellular deficiency diagnosis genetic deviation diagnosis procedure cellular protein output deficiency
12/30/2010US20100330551 Novel Restriction Endonucleases, DNA Encoding These Endonucleases and Methods for Identifying New Endonucleases with the Same or Varied Specificity
12/30/2010US20100330550 Detection of human papillomavirus
12/30/2010US20100330549 Heteroduplex tracking assay
12/30/2010US20100330548 Nucleic Acid Primers and Probes for Detecting Human and Avian Influenza Viruses
12/30/2010US20100330143 Modified macromolecules and methods of making and using thereof
12/30/2010US20100330104 Methods of using btl-ii proteins
12/30/2010US20100330097 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330080 Antigen binding polypeptides
12/30/2010US20100330079 Biomarkder combinations for colorectal cancer
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330066 Methods for Use with Baff Antagonists
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330062 Klotho protein and related compounds for the treatment and diagnosis of cancer
12/30/2010US20100330057 Method of evaluating human dentritic cells and human cell immunotherapeutic agent
12/30/2010US20100330044 Mesp1 as a master regulator of multipotent cardiovascular progenitor specification and uses thereof
12/30/2010US20100330039 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330036 Markers of matrix gene expression and cellular differentiation in chondrocytes
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329987 Uses of Sperm Membrane Protein OBF
12/30/2010US20100329982 Particles with inducible change of shape
12/29/2010WO2010151880A2 Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
12/29/2010WO2010151878A2 Rapid bed-side measurement of neutrophil elastase activity in biological fluids
12/29/2010WO2010151842A2 Methods and systems for phylogenetic analysis
12/29/2010WO2010151841A2 Single nucleotide polymorphisms in brca1 and cancer risk
12/29/2010WO2010151772A1 Method and reagents for detecting the presence or absence of a target substance in a test sample
12/29/2010WO2010151771A2 Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetella
12/29/2010WO2010151764A1 Method and reagents for detecting the presence or absence of staphylococcus aureus in a test sample
12/29/2010WO2010151751A2 Heat-treated limulus amebocyte lysates
12/29/2010WO2010151731A1 Materials and methods for the identification of drug-resistant cancers and treatment of same
12/29/2010WO2010151714A2 Molecular arrays
12/29/2010WO2010151705A2 Capture and elution of bio-analytes via beads that are used to disrupt specimens
12/29/2010WO2010151640A2 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease
12/29/2010WO2010151625A1 Methods for treating and diagnosing glucose metabolic syndrome
12/29/2010WO2010151599A1 Human leukocyte antigen alleles associated with advanced lung diseases
12/29/2010WO2010151566A1 Compositions and methods for detecting nucleic acid from mollicutes
12/29/2010WO2010151416A1 Method of measuring adaptive immunity
12/29/2010WO2010151133A1 Methods for establishing and predicting resistance to endocrine therapy using an mirna profile
12/29/2010WO2010151124A2 Selection of a nutritional composition capable of promoting health
12/29/2010WO2010150922A2 Methods for screening for anti-graying agents on the basis of aff-4
12/29/2010WO2010150901A1 Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150259A1 Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
12/29/2010WO2010150103A2 Method of preparing an adduct
12/29/2010WO2010149861A1 Method for quantitative pcr amplification of deoxyribonucleic acids from a sample containing pcr inhibitors
12/29/2010WO2010149782A1 Methods and nucleic acids for analysis of bladder cell proliferative disorders
12/29/2010WO2010149780A1 Test system for measuring mest activity as well as methods and uses involving the same
12/29/2010WO2010149767A1 Method for determining the risk of occurence of liver fibrosis in an individual
12/29/2010WO2010149640A2 Molecular markers in kidney cancer
12/29/2010WO2010149532A1 Process for amplifying dna using tetraethylene glycol, kit of parts therefor and use thereof
12/29/2010WO2010149332A2 Polynucleotides for diagnostic and prognostic of a cardiac disease
12/29/2010WO2010149202A1 Methods for diagnosing benign versus malignant thyroid lesions
12/29/2010WO2010149159A1 Dna-based methods for clone-specific identification of staphylococcus aureus
12/29/2010WO2010148927A1 Test strip container and measuring device used cooperated with test strip container
12/29/2010WO2010148651A1 Method and kit for detecting small rna
12/29/2010WO2010148447A1 A novel regulator of cellular senescence